Simbrinza (Simbrinza) Rx Price Comparison: US vs Canada

At the US pharmacies in our data, the lowest listed discount-card price for Simbrinza is around $192.73. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.

Canadian pharmacy listings in our data show Simbrinza priced from about $3.12 per tablet (converted to USD), before shipping. Pack size and pharmacy both affect the final total — see the Canada pricing table for specifics.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. Check the comparison table above for the specific numbers on Simbrinza.

Generic and brand-name pricing for Simbrinza is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

No, Simbrinza is only available as a brand-name medication at this time. There is no FDA-approved generic equivalent on the market.

Simbrinza is a prescription ophthalmic solution (eye drop) manufactured by Novartis. It is FDA-approved for lowering elevated intraocular pressure in patients diagnosed with open-angle glaucoma or ocular hypertension. The drops contain a combination of two active ingredients: brinzolamide, a carbonic anhydrase inhibitor that reduces fluid production inside the eye, and brimonidine, an alpha-2 adrenergic agonist that decreases fluid production and increases fluid drainage. By lowering the pressure within the eye, Simbrinza helps reduce the risk of optic nerve damage and vision loss. It is not intended for use in acute angle-closure glaucoma. This medication requires a doctor's prescription and is not recommended for children and adolescents between the ages of 2 and 17 years.

Common side effects of Simbrinza include blurred vision, a harmless discoloration of the white part of the eye, eye irritation, and redness. Patients may also experience dry mouth, an unpleasant taste, decreased visual acuity, eye discomfort or pain, light sensitivity, and soreness in the eyes. If any of these effects are persistent, bothersome, or worsen, you should inform your prescribing doctor. It is important to consult with an eye care specialist to determine if Simbrinza is an appropriate treatment for your condition before beginning use.